20 June 2013
Keywords: UK, Biotech, BIA, Innovation funding, Tax-advantaged investment, SMEs
Article | 03 September 2012
The outlook for the UK economy remains flat and innovative small- and medium-sized enterprises (SMEs) continue to face a squeeze ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 September 2012
4 September 2012
19 June 2013
© 2013 thepharmaletter.com